Global Virus Filtration Market - 2022-2029
Market Overview
The global virus filtration market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).
To retain virus particles, virus filtration employs a membrane barrier. A size-based virus removal method employs a specially designed polymeric membrane to retain virus particles on the membrane's surface and within its pores.
Market Dynamics
The factors influencing the global virus filtration market are the increasing R&D and the increasing prevalence of chronic diseases.
The increasing R&D is expected to drive the global virus filtration market in the forecast period
Virus filtration is an effective and robust dedicated viral clearance step used in biopharmaceutical manufacturing. Virus filtration is critical in producing biotherapeutic products because it effectively removes potential viral contaminants. Biological materials are used to produce many biopharmaceutical therapies, such as mAbs and blood plasma factors. This increases the possibility that microorganisms, such as viral contaminants, will unintentionally be introduced into the manufacturing process and contaminate the product. As a result, it is critical to remove such harmful agents using effective viral filtration methods. It is critical that downstream purification processes effectively remove actual and potential viral contaminants during biotherapeutics manufacturing from mammalian cell culture or plasma. Because virus removal by filtration is primarily a size-based mechanism, effective clearance can be achieved for various virus types, regardless of their physicochemical properties. Virus filtration is also one of the few unit operations capable of removing small nonenveloped viruses that are resistant to inactivation and may be difficult to remove via chromatography steps. Virus filtration does not affect product quality, making it an ideal solution for improving the safety of most biological products. Virus filtration is one of the most effective and robust methods of enhancing the safety of biological products. Hence, the increasing use of virus filtration in biopharmaceutical R&D processes is expected to drive market growth in the forecast period.
The problems associated with virus filtration is expected to hamper the market growth
There are various problems associated with virus filtration, which are expected to hamper market growth. For instance, because of the non-representative volumetric throughputs (L/m2) that can be seen with the addition of the virus spike, the traditional approach to virus filter spiking studies (virus added to the feed solution before the start of filtration) can result in large viral filtration systems. The reduction in throughput results from interactions between the species in the virus stock solution alone or combined with the species in the drug product. The conventional approach assumes that virus filter log reduction value (LRV) is directly related to volumetric throughput and limits manufacturing scale designs to the volumetric throughput obtained in the spiking study. Implementing a virus-retentive filter is just one of the many steps a manufacturer will take to ensure product safety. The selection of a virus filter is primarily influenced by robust virus retention. Nonetheless, strong retention should be achieved as cheaply as possible. This brief overview of regulatory, process and filter-related considerations should help filter users choose the right virus filter and begin filter optimization studies. Hence, choosing a virus filter is an important step and can impact the process.
COVID-19 Impact Analysis
Central furnace filters, also known as HVAC filters, filter the air throughout a home. Portable air cleaners and HVAC filters can help to reduce airborne pollutants in the home, including viruses. Portable air cleaners and HVAC filters are insufficient to protect people from the virus that causes COVID-19. Portable air filters effectively remove SARS-CoV-2 particles from the air, according to research at a hospital swamped by people with COVID-19, the first such evidence in a real-world setting. According to the study, the findings suggest that air filters could be used in hospitals to reduce the risk of patients and medical staff contracting SARS-CoV-2. Despite personal protective equipment, hospitals have reported significant SARS-CoV-2 transmission from patients to healthcare workers. Viral particles in the air, which are one of the main drivers of SARS-CoV-2 transmission, are one suspected cause of such cases. Hence, the global virus filtration market is expected to grow during COVID-19, increasing the demand for portable air cleaners and HVAC filters.
Segment Analysis
The kits, reagents, and consumables segment is expected to dominate the market growth
The kits, reagents, and consumables category are significant in the virus filtration market. The reagents help to reduce the risk of pathogenic virus transmission during surgery. The reagents aid in identifying viruses that are likely to contaminate the cell substrate or any other reagents or materials used during the evaluation process.
Qiagen and Merck Millipore are two well-known manufacturers of virus filtration reagents and kits. Blood, plasma, serum, or bodily fluids, as well as monoclonal antibodies and recombinant proteins, may be used to produce biopharmaceuticals. Several biologic and pharmaceutical companies are also increasing their investments in the research and development of vaccines, protein therapeutics, blood products, cellular therapy products, gene therapy products, tissue products, etc.
Geographical Analysis
North America region is expected to hold the largest market share in the global virus filtration market
Due to an increase in disease incidence and more pharmaceutical companies in the region. The United States has the largest market share in North America. Furthermore, there has been increased regulatory scrutiny involving adventitious viruses in manufacturing processes in recent years. Biologics demand is expected to drive the viral filtration market during the forecast period, owing to increased R&D by biopharmaceutical companies. The presence of major companies in this region is also expected to drive market growth. For instance, Pall Corporation manufactures high-tech filtration, separation, and purification, serving customers' diverse needs in various applications. The company is headquartered in Port Washington, United States. The company manufactures Pegasus Prime Virus Removal Filter Membrane in Pall Kleenpa Nova Capsules and Cartridges. The first gamma-sterilized pre-filter and virus filter combination is pegasus protect virus prefiltration combined with prime virus filtration. Hence, major key players in this region are expected to boost market growth.
Competitive Landscape
The global virus filtration market is moderately competitive with mergers, collaborations, and product launches. Some of the key players in this market are Asahi Kasei Medical Co. Ltd, Charles River Laboratories International Inc., General Electric Company, Pall Corporation, Merck KgaA, Sartorius Group, Pendotech
Asahi Kasei Medical Co. Ltd
Overview: Asahi Kasei Corp. develops fiber products, chemicals, and electronic related materials and globally pursues growth opportunities in areas that can leverage technological advantages. The company was founded in 1974.
Product Portfolio: Planova BioEX is an excellent virus filter choice for biopharmaceutical products due to its superior filtration performance, robust virus removability, and unrivaled quality.
Why Purchase the Report?
Visualize the composition of the global virus filtration market segmentation by product, by application, and end-user highlighting the key commercial assets and players.
Identify commercial opportunities in global virus filtration market by analyzing trends and co-development deals.
Excel data sheet with thousands of data points of global virus filtration market- level 4/5 segmentation.
PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
Product mapping in excel for the key product of all major market players
The global virus filtration market report would provide an access to an approx. 45+market data table, 40+figures and 190 pages.
Target Audience
Service Providers/ Buyers
Industry Investors/Investment Bankers
Education & Research Institutes
Research Professionals
Emerging Companies
Manufacturers
Market Segmentation
Global Virus Filtration Market- By Product
Kits, Reagents, and Consumables
Filtration Systems
Services
Global Virus Filtration Market-By Application
Biological
Vaccines and Therapeutics
Blood and Blood Products
Cellular and Gene Therapy Products
Tissue and Tissue Products
Other
Medical Devices
Water Purification
Air Purification
Other
Global Virus Filtration Market- By End User
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)
Other
Global Virus Filtration Market- By Region
North America
Europe
South America
Asia Pacific
Middle East and Africa
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook